Myoglobin-associated acute kidney injury in the setting of ciprofloxacin administration

American Journal of Kidney Diseases

Volumn 59, Issue 3, 2012, Pages 462-466

  Qian, Qi ^a   Nasr, Samih H ^a   Akogyeram, Clement O ^a   Sethi, Sanjeev ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

ciprofloxacin; drug toxicity; Myoglobin; pigment associated kidney injury; rhabdomyolysis

Indexed keywords

CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CREATININE; MYOGLOBIN;

ACUTE KIDNEY FAILURE; ADULT; ANAMNESIS; ARTICLE; BRONCHIECTASIS; BRONCHITIS; CASE REPORT; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; LUNG TRANSPLANTATION; MALE; URINALYSIS;

ACUTE KIDNEY INJURY; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; HUMANS; MALE; MIDDLE AGED; MYOGLOBIN;

EID: 84857358451     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.10.051     Document Type: Article

References (27)

1. Y.S. Chatzizisis, G. Misirli, A.I. Hatzitolios, G.D. Giannoglou The syndrome of rhabdomyolysis: complications and treatment Eur J Intern Med 19 2008 568 574
2. Y.S. Chatzizisis, K.C. Koskinas, G. Misirli, C. Vaklavas, A. Hatzitolios, G.D. Giannoglou Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment Drug Saf 33 2010 171 187
3. S.H. Hsiao, C.M. Chang, C.J. Tsao, Y.Y. Lee, M.Y. Hsu, T.J. Wu Acute rhabdomyolysis associated with ofloxacin/levofloxacin therapy Ann Pharmacother 39 2005 146 149
4. M.M. Hall, J.T. Finnoff, J. Smith Musculoskeletal complications of fluoroquinolones: guidelines and precautions for usage in the athletic population PM R 3 2011 132 142
5. Y.H.K. Fujii, S. Enomoto A case of rhabdomyolysis apparently induced by ciprofloxacin hydrochloride complicated by acute renal failure J Wakayama Med Soc 49 1998 361 386 (Pubitemid 28377753)
6. P. Stratta, E. Lazzarich, C. Canavese, C. Bozzola, G. Monga Ciprofloxacin crystal nephropathy Am J Kidney Dis 50 2007 330 335 (Pubitemid 47095080)
7. M.C. Dalakas Toxic and drug-induced myopathies J Neurol Neurosurg Psychiatry 80 2009 832 838
8. S. Rastogi, J.L. Atkinson, J.T. McCarthy Allergic nephropathy associated with ciprofloxacin Mayo Clin Proc 65 1990 987 989 (Pubitemid 20247047)
9. M. Tuccori, B. Guidi, G. Carulli, C. Blandizzi, M. Del Tacca, M. Di Paolo Severe thrombocytopenia and haemolytic anaemia associated with ciprofloxacin: a case report with fatal outcome Platelets 19 2008 384 387
10. V.R. Dharnidharka, K. Nadeau, C.L. Cannon, H.W. Harris, S. Rosen Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes Am J Kidney Dis 31 1998 710 712
11. J. Sendzik, M. Shakibaei, M. Schafer-Korting, R. Stahlmann Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells Toxicology 212 2005 24 36 (Pubitemid 40807461)
12. F. Pouzaud, K. Bernard-Beaubois, M. Thevenin, J.M. Warnet, G. Hayem, P. Rat In vitro discrimination of fluoroquinolones toxicity on tendon cells: involvement of oxidative stress J Pharmacol Exp Ther 308 2004 394 402 (Pubitemid 38090742)
13. S. Guis, D. Bendahan, G. Kozak-Ribbens Investigation of fluoroquinolone-induced myalgia using (31)P magnetic resonance spectroscopy and in vitro contracture tests Arthritis Rheum 46 2002 774 778 (Pubitemid 34214259)
14. D.A. Lowes, C. Wallace, M.P. Murphy, N.R. Webster, H.F. Galley The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells Free Radic Res 43 2009 323 328
15. R.D. Sawant Rhabdomyolysis due to an uncommon interaction of ciprofloxacin with simvastatin Can J Clin Pharmacol 16 2009 e78 e79
16. X. Bosch, E. Poch, J.M. Grau Rhabdomyolysis and acute kidney injury N Engl J Med 361 2009 62 72
17. P.J. Poels, F.J. Gabreels Rhabdomyolysis: a review of the literature Clin Neurol Neurosurg 95 1993 175 192 (Pubitemid 23288234)
18. G.D. Giannoglou, Y.S. Chatzizisis, G. Misirli The syndrome of rhabdomyolysis: pathophysiology and diagnosis Eur J Intern Med 18 2007 90 100 (Pubitemid 46330785)
19. M.J. Tracz, J. Alam, K.A. Nath Physiology and pathophysiology of heme: implications for kidney disease J Am Soc Nephrol 18 2007 414 420 (Pubitemid 46193307)
20. J. Borras-Blasco, V. Conesa-Garcia, A. Navarro-Ruiz, F. Marin-Jimenez, M. Gonzalez-Delgado, A. Gomez-Corrons Ciprofloxacin, but not levofloxacin, affects cyclosporine blood levels in a patient with pure red blood cell aplasia Am J Med Sci 330 2005 144 146 (Pubitemid 41376783)
21. S.W. Altmann, H.R. Davis Jr, L.J. Zhu Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption Science 303 2004 1201 1204 (Pubitemid 38233587)
22. H.R. Davis Jr, L.J. Zhu, L.M. Hoos Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis J Biol Chem 279 2004 33586 33592 (Pubitemid 39063007)
23. M. Florentin, E.N. Liberopoulos, M.S. Elisaf Ezetimibe-associated adverse effects: what the clinician needs to know Int J Clin Pract 62 2008 88 96 (Pubitemid 350294010)
24. C. Simard, P. Poirier Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Can J Cardiol 22 2006 141 144
25. L.A. Weffald, L.A. Flach Myopathy associated with atorvastatin-ezetimibe combination therapy Pharmacotherapy 27 2007 309 311 (Pubitemid 46214593)
26. R. Fux, K. Morike, U.F. Gundel, R. Hartmann, C.H. Gleiter Ezetimibe and statin-associated myopathy Ann Intern Med 140 2004 671 672
27. C.A. Naranjo, U. Busto, E.M. Sellers A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 1981 239 245 (Pubitemid 12149145)